Related Experiment Video
Updated: May 28, 2026
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Targeting heat shock response pathways to treat pancreatic cancer
Yi Xia1, Palma Rocchi, Juan L Iovanna
1Centre Interdisciplinaire de Nanoscience de Marseille, Département de Chimie, CNRS UPR 3118, 163 Avenue de Luminy, 13288 Marseille, France.
Abstract:
Pancreatic cancer belongs to the group of extremely aggressive human cancers; conventional cancer treatments have little impact. Increasing understanding of the pathways associated with pancreatic cancer progression has enabled the development of targeted therapy on this cancer. Heat shock proteins (HSPs) and related heat shock response (HSR) pathways control multiple important oncogenic pathways for pancreatic cancer development. Consequently, they represent promising novel targets for pancreatic cancer therapy. Various strategies have been proposed and elaborated to target HSPs/HSR in pancreatic cancer with the corresponding modulators, the details of which are highlighted in this review.
Insights
Targeting heat shock proteins (HSPs) and heat shock response (HSR) pathways offers a promising new strategy for pancreatic cancer therapy, given the limited efficacy of conventional treatments for this aggressive disease.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Pancreatic cancer is an aggressive malignancy with limited treatment options.
- Conventional therapies show minimal impact on pancreatic cancer progression.
- Understanding cancer-specific pathways is crucial for developing targeted treatments.
Purpose of the Study:
- To review the role of heat shock proteins (HSPs) and heat shock response (HSR) in pancreatic cancer.
- To explore the potential of targeting HSPs/HSR pathways as a novel therapeutic strategy for pancreatic cancer.
- To summarize current and proposed strategies for modulating HSPs/HSR in pancreatic cancer treatment.
Main Methods:
- Literature review of studies on pancreatic cancer, HSPs, and HSR.
- Analysis of oncogenic pathways regulated by HSPs/HSR in pancreatic cancer.
- Compilation of proposed therapeutic strategies targeting HSPs/HSR modulators.
Main Results:
- HSPs and HSR pathways are implicated in multiple critical oncogenic pathways driving pancreatic cancer.
- These pathways represent significant and promising therapeutic targets for pancreatic cancer.
- Various modulators and strategies targeting HSPs/HSR have been proposed and developed.
Conclusions:
- Targeting HSPs/HSR pathways presents a viable and novel therapeutic avenue for pancreatic cancer.
- Further research and clinical development of HSPs/HSR modulators are warranted.
- This review highlights the potential of HSPs/HSR-targeted therapies to improve outcomes for pancreatic cancer patients.
